Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

NCT03739684 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Prostate Adenocarcinoma
Prostate Cancer Recurrent
Prostate Cancer Metastatic

Interventions

DRUG: 18F-DCFPyL
DIAGNOSTIC_TEST: PET/CT Imaging

Sponsor

Progenics Pharmaceuticals, Inc.